Table 1.
Baseline characteristics of study participants (n = 16).
| Body Composition | Patients’ Data | Nutritional Status | Patients’ Data |
|---|---|---|---|
| Age (Years) | 55.2 ± 7.2 | Total energy intake(kcal) | 1646 ± 411 |
| SBP (mmHg) | 126.4 ± 13.4 | Carbohydrate (%) | 51.4 ± 14.7 |
| DBP (mmHg) | 83.8 ± 11.9 | Protein (%) | 16.3 ± 2.0 |
| Hear rate (bpm) | 75.0 (68.3, 80.8) | Fat (%) | 28.8 ± 10.6 |
| Metabolic parameters | SFA (%) | 5.2 (2.1, 7.3) | |
| BMI (kg/m2) | 26.0 ± 1.3 | MUFA (%) | 6.1 (4.1, 8.7) |
| Waist circumference(cm) | 87.8 ± 5.6 | PUFA (%) | 8.7 (5.0, 14.8) |
| Skeletal muscle (kg) | 22.2 (21.5, 22.9) | Omega-6 (%) | 0.5 (0.1, 1.6) |
| Fat mass (kg) | 23.4 ± 3.5 | Omega-3 (%) | 2.2 (0.8, 9.3) |
| Fat percentage (%) | 36.3 ± 4.3 | Hormone status | |
| GLTEQ score (MET-h/week) | 9.3 (0, 28) | ER−/PR− | 4 (25%) |
| Glucose (mg/dL) | 90.1 ± 12.0 | ER+/PR− | 2 (12.5%) |
| Insulin (mU/L) | 8.1 ± 2.8 | ER−/PR+ | 1 (6.25%) |
| HOMA-IR | 1.8 ± 0.8 | ER+/PR+ | 9 (56.25%) |
| Total cholesterol (mg/dL) | 198.0 ± 26.3 | Staging | |
| Triglyceride (mg/dL) | 148.4 ± 67.6 | IA | 9(56.3%) |
| HDL cholesterol (mg/dL) | 56.0 ± 9.9 | IIA | 4(25%) |
| LDL cholesterol (mg/dL) | 112.3 ± 24.3 | IIB | 3 (18.7%) |
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment of insulin resistance; HDL, high density lipoprotein; LDL, low density lipoprotein; GLTEQ, Godin Leisure-Time Exercise Questionnaire; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; ER, estrogen receptor; and PR, progesterone receptor. Data are presented as mean ± standard deviations for continuous variables with normal distribution or median (25th, 75th) for continuous variables with markedly skewed distribution or number (percentage) for categorical variables.